AstraZeneca (France)

“Artificial intelligence”: Which services, which applications, which results and which development today in clinical research? Which impact on the quality of care? Which recommendations?

Vincent Diebolt, I Azancot, François‐Henri Boissel et al.

2018 · 15 Zit.

What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?

Alexandre Pariente, Joëlle Micallef, Amir Lahouegue et al.

2022 · 8 Zit.

« Intelligence artificielle » : quels services, quelles applications, quels résultats et quelle valorisation aujourd’hui en recherche clinique ? Quel impact sur la qualité des soins ? Quelles recommandations ?

Vincent Diebolt, I Azancot, François‐Henri Boissel et al.

2018 · 1 Zit.

Artificial intelligence and clinical guidelines to find at-risk COPD patients for treatment optimisation

Alex Veldman, Jad El Khoury, Norbert Feigler et al.

2025 · 0 Zit.

"Artificial intelligence": Which services, which applications, which results and which development today in clinical research? Which impact on the quality of care? Which recommendations?

Vincent Diebolt, I Azancot, François‐Henri Boissel et al.

2019 · 0 Zit.

Leveraging AI and clinical guidelines to identify undiagnosed and under-treated CKD patients for treatment optimisation

Alex Veldman, Elmas Malvolti, P Desai et al.

2025 · 0 Zit.

Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?

Alexandre Pariente, Joëlle Micallef, Amir Lahouegue et al.

2022 · 0 Zit.